Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00509444 | Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial(CPTD) | completed | Phase 3 | 200 | Johns Hopkins Bloomberg School of Public HealthOTHER | 1 | Apr 20, 2017 | clinicaltrials |
| NCT01642771 | Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast Cancer | unknown | Phase 3 | 636 | China Breast Cancer Clinical Study GroupOTHER | 1 | Apr 19, 2017 |
| clinicaltrials |
| NCT01539317 | Therapy to Prevent Sexual Pain in Breast Cancer Survivors | completed | Phase 3 | 50 | OHSU Knight Cancer InstituteOTHER | 1 | Apr 14, 2017 | clinicaltrials |
| NCT01385137 | S0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone Thpy | completed | Phase 3 | 262 | SWOG Cancer Research NetworkNETWORK | 1 | Apr 7, 2017 | clinicaltrials |
| NCT01007942 | Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer(BOLERO-3) | completed | Phase 3 | 569 | Novartis PharmaceuticalsINDUSTRY | 21 | Apr 5, 2017 | clinicaltrials |
| NCT00956813 | Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen Therapy | completed | Phase 3 | 210 | Alliance for Clinical Trials in OncologyOTHER | 1 | Apr 4, 2017 | clinicaltrials |
| NCT00331097 | ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment | completed | Phase 3 | 300 | National Cancer Institute, NaplesOTHER | 1 | Mar 28, 2017 | clinicaltrials |
| NCT00296036 | Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer | completed | Phase 3 | 137 | Alliance for Clinical Trials in OncologyOTHER | 1 | Mar 16, 2017 | clinicaltrials |
| NCT01331629 | Impact of Art Therapy on Fatigue and Quality of Life of Patients Treated With Adjuvant Radiotherapy for Breast Cancer(ART-THERAPIE) | completed | Phase 2 / Phase 3 | 322 | Centre Francois BaclesseOTHER | 1 | Mar 14, 2017 | clinicaltrials |
| NCT01572727 | A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation(BELLE-4) | completed | Phase 2 / Phase 3 | 416 | Novartis PharmaceuticalsINDUSTRY | 22 | Mar 9, 2017 | clinicaltrials |
| NCT01762020 | Barrier Film vs. Standard Skin Care in Preventing Dermatitis in Women With Breast Cancer Receiving Radiation | completed | Phase 3 | 56 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Mar 8, 2017 | clinicaltrials |
| NCT02144012 | A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine Versus the Combination of Trastuzumab Plus Docetaxel in Patients With HER2-positive Breast Cancer | terminated | Phase 3 | 49 | Hoffmann-La RocheINDUSTRY | 4 | Mar 7, 2017 | clinicaltrials |
| NCT00171704 | A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer | completed | Phase 3 | 263 | Novartis PharmaceuticalsINDUSTRY | 2 | Mar 3, 2017 | clinicaltrials |
| NCT01479244 | Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence(PRESENT) | completed | Phase 3 | 758 | Galena Biopharma, Inc.INDUSTRY | 13 | Feb 27, 2017 | clinicaltrials |
| NCT00329940 | Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer | completed | Phase 3 | 200 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 24, 2017 | clinicaltrials |
| NCT00332852 | Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer | completed | Phase 3 | 655 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 23, 2017 | clinicaltrials |
| NCT01626222 | 4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer(MACS2096) | completed | Phase 3 | 301 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00330317 | Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer | completed | Phase 3 | 300 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 7, 2017 | clinicaltrials |
| NCT00695916 | MRI in Women With Newly Diagnosed Breast Cancer Prior to Breast Conserving Surgery | withdrawn | Phase 3 | 0 | Stanford UniversityOTHER | 0 | Feb 1, 2017 | clinicaltrials |
| NCT00156806 | Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer. | completed | Phase 3 | 231 | AHS Cancer Control AlbertaOTHER | 1 | Jan 24, 2017 | clinicaltrials |
| NCT03006614 | PERS Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast Cancer(PERS) | unknown | Phase 3 | 320 | Shi YanxiaOTHER | 1 | Jan 16, 2017 | clinicaltrials |
| NCT02213744 | MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients(HERMIONE) | terminated | Phase 2 / Phase 3 | 113 | Merrimack PharmaceuticalsINDUSTRY | 9 | Jan 6, 2017 | clinicaltrials |
| NCT01708798 | Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer | terminated | Phase 2 / Phase 3 | 44 | University of British ColumbiaOTHER | 1 | Jan 5, 2017 | clinicaltrials |
| NCT02609321 | Efficacy of Thoracic Paravertebral Block in the Reduction of Acute Post-surgical Pain in Patients With Breast Cancer | completed | Phase 3 | 60 | Instituto de Cancerología S.A.OTHER | 1 | Dec 26, 2016 | clinicaltrials |
| NCT00363909 | Citalopram in Treating Postmenopausal Women With Hot Flashes | completed | Phase 3 | 254 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 13, 2016 | clinicaltrials |
| NCT01986569 | Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer | completed | Phase 3 | 93 | Asan Medical CenterOTHER | 1 | Dec 8, 2016 | clinicaltrials |
| NCT00107263 | Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer | completed | Phase 3 | 558 | Alliance for Clinical Trials in OncologyOTHER | 0 | Dec 6, 2016 | clinicaltrials |
| NCT02860104 | Ultrasound Guided Percutaneous Microwave Ablation for Breast Lesions | unknown | Phase 2 / Phase 3 | 500 | Chinese PLA General HospitalOTHER | 1 | Nov 23, 2016 | clinicaltrials |
| NCT00912444 | Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast Cancer(NATT) | terminated | Phase 3 | 102 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Nov 22, 2016 | clinicaltrials |
| NCT00021255 | Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer | completed | Phase 3 | 3,222 | SanofiINDUSTRY | 42 | Nov 15, 2016 | clinicaltrials |
| NCT02958033 | Shandong Cancer Hospital Affiliated to Shandong University | unknown | Phase 3 | 100 | Shandong Cancer Hospital and InstituteOTHER | 1 | Nov 8, 2016 | clinicaltrials |
| NCT00661102 | A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). | completed | Phase 3 | 598 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT00829166 | A Study of Trastuzumab Emtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer(EMILIA) | completed | Phase 3 | 991 | Hoffmann-La RocheINDUSTRY | 27 | Oct 31, 2016 | clinicaltrials |
| NCT00066807 | Premenopausal Endocrine Responsive Chemotherapy Trial(PERCHE) | terminated | Phase 3 | 29 | ETOP IBCSG Partners FoundationNETWORK | 3 | Oct 28, 2016 | clinicaltrials |
| NCT01419197 | A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy(TH3RESA) | completed | Phase 3 | 602 | Hoffmann-La RocheINDUSTRY | 22 | Oct 12, 2016 | clinicaltrials |
| NCT02830685 | Pre-pectoral Breast Reconstruction PART 1(PreBRec) | unknown | Phase 3 | 131 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Oct 3, 2016 | clinicaltrials |
| NCT02831426 | Pre-pectoral Breast Reconstruction PART 2(PreBRec) | unknown | Phase 3 | 86 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Oct 3, 2016 | clinicaltrials |
| NCT00022516 | Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer(22-00) | completed | Phase 3 | 1,086 | ETOP IBCSG Partners FoundationNETWORK | 11 | Sep 16, 2016 | clinicaltrials |
| NCT01246427 | Evaluation of Homeopathic Treatment for Hot Flashes in Non Metastatic Breast Cancer(HBC) | completed | Phase 3 | 138 | Centre Leon BerardOTHER | 1 | Sep 14, 2016 | clinicaltrials |
| NCT00190489 | A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer | completed | Phase 3 | 450 | Japan Clinical Oncology GroupOTHER | 1 | Sep 2, 2016 | clinicaltrials |
| NCT00868634 | Capecitabine and Bevacizumab ± Vinorelbine in Metastatic Breast Cancer(CARIN) | completed | Phase 3 | 600 | iOMEDICO AGINDUSTRY | 1 | Aug 31, 2016 | clinicaltrials |
| NCT00357734 | Iressa Follow-up Trial | completed | Phase 3 | 14 | AstraZenecaINDUSTRY | 1 | Aug 30, 2016 | clinicaltrials |
| NCT01413828 | Trastuzumab Administered Concurrently or Sequentially to Anthracycline-containing Adjuvant Regimen for Breast Cancer | completed | Phase 2 / Phase 3 | 201 | Peking Union Medical College HospitalOTHER | 1 | Aug 17, 2016 | clinicaltrials |
| NCT00024102 | Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer | completed | Phase 3 | 633 | Alliance for Clinical Trials in OncologyOTHER | 3 | Aug 12, 2016 | clinicaltrials |
| NCT00343382 | Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer | completed | Phase 3 | 201 | Alliance for Clinical Trials in OncologyOTHER | 1 | Aug 12, 2016 | clinicaltrials |
| NCT00692458 | A Study to Assess the Effects of MK0822 in Reducing the Risk of Bone Metastasis in Women With Breast Cancer (0822-029) | withdrawn | Phase 3 | 0 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 12, 2016 | clinicaltrials |
| NCT02865304 | The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients | unknown | Phase 3 | 80 | Fujian Cancer HospitalOTHER_GOV | 0 | Aug 12, 2016 | clinicaltrials |
| NCT02104895 | Accelerated Partial Breast Irradiation Using Intensity Modulated Radiotherapy Versus Whole Breast Irradiation | completed | Phase 3 | 520 | Azienda Ospedaliero-Universitaria CareggiOTHER | 0 | Aug 11, 2016 | clinicaltrials |
| NCT00805597 | Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes | terminated | Phase 3 | 40 | Chinese Academy of Medical SciencesOTHER | 1 | Aug 8, 2016 | clinicaltrials |
| NCT01568346 | Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy | terminated | Phase 3 | 9 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 2, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Apr 20, 2017source: clinicaltrials